Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (591-600 of 1,833) with videos related to

Pageof 184
Sort By:
Mabs|March 29, 2011
Analytical methods for physicochemical characterization of antibody drug conjugatesAditya Wakankar, Yan Chen, Yatin Gokarn, et al.
Mabs|March 29, 2011
Worldwide experience with biosimilar developmentMark McCamish, Gillian Woollett
Mabs|March 2, 2011
Letter from the Editor: stratified medicineJanice M Reichert
Mabs|March 2, 2011
Therapeutic antibodies in ophthalmology: old is new againCharlotte Magdelaine-Beuzelin, Coralie Pinault, Gilles Paintaud, et al.
Mabs|April 14, 2011
A novel synthetic naïve human antibody library allows the isolation of antibodies against a new epitope of oncofetal fibronectinAlessandra Villa, Valeria Lovato, Emil Bujak, et al.
Mabs|May 5, 2011
A single mutation turns a non-binding germline-like predecessor of broadly neutralizing antibody into a binding antibody to HIV-1 envelope glycoproteinsTingting Yuan, Jingjing Li, Mei-Yun Zhang
Mabs|May 5, 2011
Highly specific off-target binding identified and eliminated during the humanization of an antibody against FGF receptor 4Daniela Bumbaca, Anne Wong, Elizabeth Drake, et al.
Mabs|June 24, 2011
Emerging antibody combinations in oncologyStephen J Demarest, Kandasamy Hariharan, Jianying Dong
Mabs|November 26, 2010
Concentrations of EpCAM ectodomain as found in sera of cancer patients do not significantly impact redirected lysis and T-cell activation by EpCAM/CD3-bispecific BiTE antibody MT110Silke Petsch, Olivier Gires, Dominik Rüttinger, et al.
Mabs|December 15, 2010
Monoclonal antibodies in neuro-oncology: Getting past the blood-brain barrierLois A Lampson
Pageof 184

Showing results (591-600 of 1,833) with videos related to

Sort By:
Pageof 184
Mabs|March 29, 2011
Analytical methods for physicochemical characterization of antibody drug conjugatesAditya Wakankar, Yan Chen, Yatin Gokarn, et al.
Mabs|March 29, 2011
Worldwide experience with biosimilar developmentMark McCamish, Gillian Woollett
Mabs|March 2, 2011
Letter from the Editor: stratified medicineJanice M Reichert
Mabs|March 2, 2011
Therapeutic antibodies in ophthalmology: old is new againCharlotte Magdelaine-Beuzelin, Coralie Pinault, Gilles Paintaud, et al.
Mabs|April 14, 2011
A novel synthetic naïve human antibody library allows the isolation of antibodies against a new epitope of oncofetal fibronectinAlessandra Villa, Valeria Lovato, Emil Bujak, et al.
Mabs|May 5, 2011
A single mutation turns a non-binding germline-like predecessor of broadly neutralizing antibody into a binding antibody to HIV-1 envelope glycoproteinsTingting Yuan, Jingjing Li, Mei-Yun Zhang
Mabs|May 5, 2011
Highly specific off-target binding identified and eliminated during the humanization of an antibody against FGF receptor 4Daniela Bumbaca, Anne Wong, Elizabeth Drake, et al.
Mabs|June 24, 2011
Emerging antibody combinations in oncologyStephen J Demarest, Kandasamy Hariharan, Jianying Dong
Mabs|November 26, 2010
Concentrations of EpCAM ectodomain as found in sera of cancer patients do not significantly impact redirected lysis and T-cell activation by EpCAM/CD3-bispecific BiTE antibody MT110Silke Petsch, Olivier Gires, Dominik Rüttinger, et al.
Mabs|December 15, 2010
Monoclonal antibodies in neuro-oncology: Getting past the blood-brain barrierLois A Lampson
Pageof 184